Dovetailing the "Leading Change" theme of this year's Cardinal Health Retail Business Conference, independent pharmacists speak out about what change looks like for their businesses, what the future holds for community pharmacy and how to lead change in their stores and communities.
The theme for this year’s Cardinal Health RBC 2014 is “Leading Change.” For community pharmacists, that means playing a more active role in patient care. And Cardinal Health has a suite of services to help community pharmacists take the next step in making a difference in their patients’ lives — the Cardinal Health Adherence Suite.
Community pharmacists play a vital role in helping patients live healthier lives, as well as in improving the cost-effectiveness of health care. That’s a key message that community pharmacists will convey during the upcoming Health on the National Mall event.
Nearly 8,000 attendees will converge in Washington, D.C., in July for Cardinal Health’s annual Retail Business Conference, which provides independent pharmacists and pharmacy franchise owners an opportunity to network with and learn from peers, as well as gain new insights into improving business effectiveness and efficiency.
According to a report from the American Academy of Family Physicians, the Advisory Committee on Immunization Practices for the Centers for Disease Control and Prevention voted unanimously to recommend that healthy children between the ages of 2 years and 8 years be inoculated with a live attenuated influenza vaccine like FluMist, as opposed to the traditional flu shot.
Diplomat Pharmacy on Thursday announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to the proposed initial public offering of its common stock.
Roche on Wednesday announced that Genentech, a member of the Roche Group, has entered into a definitive agreement to acquire Seragon Pharmaceuticals, a privately held biotechnology company based in San Diego.
A study published Tuesday online by the journal Pediatrics found that the protective benefits provided by vaccines for children significantly outweighed the extremely rare possiblity of an adverse event.
Health care providers wrote 259 million prescriptions for opioid painkillers in 2012 — many more in some states than in others — according to a Vital Signs report released Tuesday by the Centers for Disease Control and Prevention that highlights the danger of overdose.
The Food and Drug Administration on Tuesday issued several policy documents regarding compounding as part of the agency’s continuing effort to implement the compounding provisions of the Drug Quality and Security Act enacted in November 2013.
Actavis on Wednesday announced that its subsidiary Forest Labs has successfully completed its acquisition of Furiex Pharmaceuticals in an all-cash transaction valued at approximately $1.1 billion, and up to approximately $360 million in a Contingent Value Right that may be payable based on the status of eluxadoline, Furiex's lead product, as a controlled drug, following approval.
As many as 32 organizations on Tuesday signed a letter calling on the Food and Drug Administration to require biologics and biosimilars to have the same International Nonproprietary Name, a practice currently in use in Europe and other markets.